Day: August 18, 2025

Home » Myelodysplastic Syndrome » Vidaza® Improves Survival in Myelodysplastic Syndromes According to a press release by Pharmion, Vidaza™ (azacitidine) significantly improves survival compared with conventional care in the treatment of myelodysplastic syndromes.